EGFR and non-small cell lung carcinoma: In this study, we performed biological information analyses, next-generation sequencing (NGS) detection, immunohistochemistry (IHC), and multiple immunohistochemistry to evaluate PD-L1, TMB, and immune cell infiltration in subtypes of EGFR-mutated NSCLC.